返回
Trigeminal neuralgia
DOI:10.1038/s41572-024-00523-z.png)
摘要
En 中文
Trigeminal neuralgia (TN) is a facial pain disorder characterized by intense and paroxysmal pain that profoundly affects quality of life and presents complex challenges in diagnosis and treatment. TN can be categorized as classical, secondary and idiopathic. Epidemiological studies show variable incidence rates and an increased prevalence in women and in the elderly, with familial cases suggesting genetic factors. The pathophysiology of TN is multifactorial and involves genetic predisposition, anatomical changes, and neurophysiological factors, leading to hyperexcitable neuronal states, central sensitization and widespread neural plasticity changes. Neurovascular compression of the trigeminal root, which undergoes major morphological changes, and focal demyelination of primary trigeminal afferents are key aetiological factors in TN. Structural and functional brain imaging studies in patients with TN demonstrated abnormalities in brain regions responsible for pain modulation and emotional processing of pain. Treatment of TN involves a multifaceted approach that considers patient-specific factors, including the type of TN, with initial pharmacotherapy followed by surgical options if necessary. First-line pharmacological treatments include carbamazepine and oxcarbazepine. Surgical interventions, including microvascular decompression and percutaneous neuroablative procedures, can be considered at an early stage if pharmacotherapy is not sufficient for pain control or has intolerable adverse effects or contraindications. In this Primer, Ashina et al. discuss the epidemiology, pathophysiology, diagnosis, management and quality of life of patients with trigeminal neuralgia, a chronic neuropathic facial pain disorder involving one or more branches of the trigeminal nerve that causes intense paroxysms of electric shock-like pain.
Keyword:
QUALITY-OF-LIFE
CHRONIC CONSTRICTION INJURY
GAMMA-KNIFE SURGERY
NEUROPATHIC PAIN
MICROVASCULAR DECOMPRESSION
NEUROVASCULAR CONTACT
CLINICAL CHARACTERISTICS
CENTRAL SENSITIZATION
MULTIPLE-SCLEROSIS
MEDICAL-MANAGEMENT
期刊
N
IF:
60.6
论文数:
650
被引数:
3.8W
机构
引用论文
An open-label, single-arm, phase I/II study of lower-dose decitabine based therapy in patients with advanced hepatocellular carcinoma
Oncotarget
IF0
HLA class II induction in human islet cells by interferon-γ plus tumour necrosis factor or lymphotoxin
Nature
IF0
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition国际头痛学会 (IHS) 头痛分类委员会国际头痛疾病分类,第3版
CEPHALALGIA
IF4.6
Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity中枢敏化: 通过中枢神经可塑性产生疼痛超敏反应

